[Treatment of severe arterial hypertension with 2 new ganglionic blocking agents administered orally; ecolid & inversine]. 1956

I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008464 Mecamylamine A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
D002714 Chlorisondamine A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications. Chlorisondamine Chloride,Chlorisondamine Dichloride,Ecolid,Chloride, Chlorisondamine,Dichloride, Chlorisondamine
D005730 Ganglionic Blockers Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. Ganglionic Blocking Agents,Ganglioplegic Agents,Blocking Agents, Ganglionic,Ganglionic Blockaders,Agents, Ganglionic Blocking,Agents, Ganglioplegic,Blockaders, Ganglionic,Blockers, Ganglionic
D001337 Autonomic Agents Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc. Autonomic Drugs,Autonomic Effect,Autonomic Effects,Agents, Autonomic,Drugs, Autonomic,Effect, Autonomic,Effects, Autonomic

Related Publications

I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
January 1958, Archivos. Hospital Universitario General Calixto Garcia,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
April 1957, Arztliche Wochenschrift,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
March 1957, The Journal of the Florida Medical Association. Florida Medical Association,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
May 1959, La Riforma medica,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
October 1955, The Medical journal of Australia,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
January 1956, Actualites pharmacologiques,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
February 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
October 1964, Sovetskaia meditsina,
I BERCONSKY, and C M NIJENSOHN, and P LITVAK BRUNO
January 1960, Khimiia i meditsina,
Copied contents to your clipboard!